|
Printable version |
From: | "G Stolwyk" <stolwyk@wave.co.nz> |
Date: | Wed, 28 Mar 2001 13:13:59 +1200 |
Greg,
You are quite right: the
word strategic implies that the holding can be
used to block any take-over or induce the offerer to pay a high price for
it.
New takeover rules will come into effect on
July 1, but it will remain a strategic stake!
One reason for some former Fletcher executives to
be on the Board, is connected with this holding.
Page 45 of the prospectus lists the
Directors:
Dr J Villiger, Luke Moriarty, Bill Hasler and
Dr Jilly Evans have excellent international connections, financial and
bio-tech backgrounds.
The CEO, mr. Moriarty has extensive experience in
international business valuation and development.
Of the six directors, two are former Fletcher
directors.
Some people object to them being on the
Board- some critics have never read the prospectus and
thus have not seen the full line-up
of the Board.
The company is not a large one and the composition
of the Board prevents any Director from having too much influence.
RBC will be operating in the
knowledge industry and as it is financed properly, will have
access to some underrated and cheaper international investments which are now
becoming available.
The composition of the Board of Directors reflects
those objectives!
Gerry
|
|